Data processing: measuring – calibrating – or testing – Measurement system in a specific environment – Chemical analysis
Reexamination Certificate
2003-02-13
2004-11-09
Barlow, John (Department: 2863)
Data processing: measuring, calibrating, or testing
Measurement system in a specific environment
Chemical analysis
C702S019000, C702S020000, C702S027000, C435S006120
Reexamination Certificate
active
06816790
ABSTRACT:
FIELD OF THE INVENTION
The present invention relates to gene expression levels and, more particularly, to the determination of gene expression levels using nucleic acid microarrays.
BACKGROUND OF THE INVENTION
The study of gene expression levels is a focus of current research. Gene expression analysis may be carried out using microarrays. Microarrays allow for the rapid analysis of large quantities of genetic material. For a detailed discussion of microarrays, see P. O. Brown, et al., “Exploring the New World of the Genome With DNA Microarrays,” Nature Genetics v. 21, p. 33 (1999); R. J. Lipshutz, et al., “High Density Synthetic Oligonucleotide Arrays,” Nature Genetics v. 21, p. 20 (1999), the disclosures of which are incorporated by reference herein. Microarrays allow researchers to analyze the genetic information in cells, e.g., genes, to determine whether each gene is being expressed in the cell, and if so, to quantify the expression level. Since gene expression levels play a central role in determining the phenotype, the observable characteristics of the cell, the gene expression levels play a crucial part in diagnosing disease states of the cell (for example, identifying cells that are, or likely to become, cancerous), in understanding cell cycles and differentiation and in casting light upon the complex spectrum of behaviors and changes in a cell.
Microarray technologies take several different forms. Some microarrays contain billions of relatively short oligonucleotides, i.e., less than 100 base pairs, of single DeoxyriboNucleic Acid (DNA) strands, termed “probe oligonucleotides,” bonded to a substrate. Each of the probe oligonucleotides represents an “unzipped” piece of a gene available for binding with a complementary strand to which the probe oligonucleotide can be “zipped.” Ideally, many identical copies of each probe oligonucleotide are deposited onto an area, i.e., about 20 microns square, termed a “probe spot,” on the substrate. A collection of probe spots on a microarray can represent thousands of genes.
Oligonucleotide sequences which are representative of the genes of interest within a cell are called target oligonucleotides. The concentration of target oligonucleotides is a measure of gene expression levels. A number of target oligonucleotides may be complementary to the probe oligonucleotides. Each target oligonucleotide has a strong affinity for bonding, i.e., hybridizing, with the probe oligonucleotide to which it is complementary. Thus, once a solution containing target oligonucleotides is introduced into the microarray, those probe oligonucleotides of the microarray that are complementary, or nearly complementary, to target oligonucleotides in the solution will hybridize with those target oligonucleotides, producing probe spots of the microarray containing hybridized probe oligonucleotide and target oligonucleotide double strands. Other spots wherein the probe oligonucleotides are not complementary to any target oligonucleotides in the solution will contain only the unhybridized, single-stranded probe oligonucleotides. Fluorescent tags on the target oligonucleotides allow for the detection of probe spots containing hybridized probe oligonucleotides and target oligonucleotides. Thus, the target oligonucleotides present in the solution may be determined. Moreover, the intensity of the fluorescence provides a measure of how much of each target oligonucleotide is present in the target solution, and hence in the original cell.
Gene expression analysis using conventional methods, such as the Affymetrix® Genechips® and algorithms has several shortcomings. For example, in the Affymetrix® technology, each gene is typically represented by a plurality of different probes of short length, i.e., about 25 nucleotide base pairs. Since all the target oligonucleotides representing a given gene are present in roughly equal concentrations, measured intensity values of all the probe spots corresponding to that gene are expected to be virtually identical. In fact, however, there are typically sizable variations in measured hybridization intensity values among the probe spots representing a particular gene. These variations may be due to, for example, cross-hybridization, secondary structure (hybridization of segments of a single target oligonucleotide or probe oligonucleotide with one other), or stronger tendency for certain complementary pairs to hybridize than for others. Variations greatly complicate the task of determining a unique and correct expression level for each gene in the target solution.
Thus, there exists a need for an accurate and efficient technique for determining gene expression levels.
SUMMARY OF THE INVENTION
The present invention provides techniques for analyzing gene expression. In one aspect of the invention, the technique provides a method for determining a concentration level of a target nucleic acid, the target nucleic acid comprising at least one target oligonucleotide. The method determines (i) a measure of affinity value of the target oligonucleotide with a probe oligonucleotide; and (ii) a hybridization intensity value for the target oligonucleotide and the probe oligonucleotide at a probe spot. The measure of affinity value and the hybridization intensity value are used to determine the concentration level of the target nucleic acid.
The measure of affinity value may comprise a free energy of hybridization of the target oligonucleotide with the probe oligonucleotide. Further, the measure of affinity value may comprise a net rate of hybridization of the target oligonucleotide with the probe oligonucleotide.
A more complete understanding of the present invention, as well as further features and advantages of the present invention, will be obtained by reference to the following detailed description and drawings.
REFERENCES:
patent: 6228593 (2001-05-01), Lipshutz et al.
patent: 6251601 (2001-06-01), Bao et al.
patent: 6510391 (2003-01-01), Balaban
patent: 6516276 (2003-02-01), Ghandour et al.
patent: 6546340 (2003-04-01), Lipshutz et al.
patent: 2003/0186234 (2003-10-01), Kurn
Balaban, David, “Computer Software Products for Nucleic Acid Hybridization Analysis,” U.S. patent application No. 2002-0102547-A1 (Aug. 1, 2002).
DeRisi et al., “Exploring the Metabolic and Genetic Control of Gene Expression on a Genomic Scale,” Science, vol. 278, pp. 680-686 (Oct. 1997).
Li et al., “Model-Based Analysis of Oligonucleotide Arrays: Expression Index Computation and Outlier Detection,” PNAS, vol. 98, No. 1, pp. 31-36 (Jan. 2001).
Lipshutz et al., “Computer-Aided Probability Base Calling for Arrays of Nucleic Acid Probes on Chips,” U.S. patent application No. 2002-0058261-A1 (May 16, 2002).
Lipshutz et al., “High Density Synthetic Oligonucleotide Arrays,” Nature Genetics Supplement, vol. 21, pp. 20-24 (Jan. 1999).
Liu et al., “System and Computer Software Products for Comparative Gene Expression Analysis,” U.S. patent application No. 2002-0103604-A1 (Aug. 1, 2002).
Lockhart et al., “Expression Monitoring by Hybridization to High-Density Oligonucleotide Arrays,” Nature Biotechnology, vol. 14, pp. 1675-1680 (Dec. 1996).
SantaLucia, Jr., John, “A Unified View of Polymer, Dumbbell, and Oligonucleotide DNA Nearest-Neighbor Thermodynamics,” Proc. Nat'l Acad. Sci. USA, vol. 95, pp. 1460-1465 (Feb. 1998).
Selinger et al., “RNA Expression Analysis Using a 30 Base Pair ResolutionEscherichia coliGenome Array,” Nature Biotechnology, vol. 18, pp. 1262-1268 (Dec. 2000).
Grinstein Geoffrey
Held Glenn Allen
Tu Yuhai
August, Esq. Casey P.
International Business Machines - Corporation
Le John
Ryan & Mason & Lewis, LLP
LandOfFree
Method and apparatus for determining gene expression levels does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method and apparatus for determining gene expression levels, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and apparatus for determining gene expression levels will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3348054